F Cavalli

585 total citations
42 papers, 366 citations indexed

About

F Cavalli is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F Cavalli has authored 42 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F Cavalli's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). F Cavalli is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). F Cavalli collaborates with scholars based in Switzerland, Italy and United States. F Cavalli's co-authors include Emanuele Zucca, Marcel Rozencweig, G. Bonadonna, L Tschopp, Andrea Zimmermann, E Pedrinis, Aron Goldhirsch, Roland Sonntag, Torben Skovsgaard and P. Dodion and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

F Cavalli

38 papers receiving 341 citations

Peers

F Cavalli
Comparison fields: 5 of 66
  • Pathology and Forensic Medicine 206
  • Oncology 154
  • Genetics 81
  • Molecular Biology 64
  • Pulmonary and Respiratory Medicine 63
P. Dias Wickramanayake Germany
A. Gottlieb United States
S. D. Rowley United States
K.G. van der Hem Netherlands
T. K. Saikia India
Vittorio Meneghini Italy
Granada Perea Spain
Ilaria Proserpio Italy
Bodey Gp United States
Geundoo Jang South Korea
P. Dias Wickramanayake Germany View profile →
Citations per field, relative to F Cavalli
F Cavalli · 1×
Citations per year, relative to F Cavalli
F Cavalli · 1×

Countries citing papers authored by F Cavalli

Since Specialization
Citations

This map shows the geographic impact of F Cavalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Cavalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Cavalli more than expected).

Fields of papers citing papers by F Cavalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Cavalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Cavalli. The network helps show where F Cavalli may publish in the future.

Co-authorship network of co-authors of F Cavalli

This figure shows the co-authorship network connecting the top 25 collaborators of F Cavalli. A scholar is included among the top collaborators of F Cavalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Cavalli. F Cavalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 27
2 7
3 10
4 10
5 23
6 2
7 9
8 1
9 31
10
Prednimustine: the rationale for clinical development.
2
11
[Extrapulmonary small-cell carcinoma - a rarity with important therapeutic consequences].
8
12
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer
0
13
[The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
2
14 1
15
Warthin's tumor with Sjögren's syndrome and non-Hodgkin's lymphoma.
19
16
A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment.
36
17 5
18 7
19 6
20
[The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026